# Chandra Bhagat (NSE: CBPL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/CBPL · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹33 Cr, it ranks 3318th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Distribution.

Its return on equity was 2.9% in FY25. Promoters held 73.02% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹33 Cr |
| ROE | 2.9% (FY25) |
| ROCE | 9.6% (FY25) |
| Debt to equity | 0.7 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹87 Cr | ₹1 Cr |
| FY24 | ₹221 Cr | ₹2 Cr |
| FY23 | ₹120 Cr | ₹1 Cr |
| FY22 | ₹94 Cr | ₹1 Cr |
| FY21 | ₹71 Cr | ₹0 Cr |
| FY20 | ₹94 Cr | ₹0 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 73.02%
- Non-institutions: 26.98%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [JFL Life Scienc](https://app.pivotnow.in/stock/JFLLIFE) | ₹10.30 | ₹34 Cr | 0.2 | — |
| [Sharma East Ind](https://app.pivotnow.in/stock/SHARMEH) | — | ₹33 Cr | — | — |
| [Deccan Health C](https://app.pivotnow.in/stock/DECCAN) | — | ₹32 Cr | — | — |
| [Medi-Caps](https://app.pivotnow.in/stock/MEDICAPQ) | ₹25.50 | ₹32 Cr | — | — |
| [KK Shah Hospita](https://app.pivotnow.in/stock/KKSHL) | — | ₹30 Cr | — | — |
| [Panjon](https://app.pivotnow.in/stock/PANJON) | — | ₹30 Cr | — | — |

## Questions and answers

### What is the market cap of Chandra Bhagat?

Chandra Bhagat's market capitalisation is ₹33 Cr (₹33 Cr) at the 22 Oct 2026 close, ranking 3318th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Chandra Bhagat?

Return on equity was 2.9% in FY25 and return on capital employed was 9.6% in FY25 (standalone figures).

### Is Chandra Bhagat a debt-free company?

No. Chandra Bhagat's debt-to-equity ratio was 0.7 in FY25, with total debt of ₹2 Cr.

### What is the shareholding pattern of Chandra Bhagat?

As of 31 Mar 2026: promoters 73.02%, non-institutions 26.98%.

### Who are Chandra Bhagat's competitors?

The listed Pharma & Healthcare companies closest to Chandra Bhagat by market cap are JFL Life Scienc, Sharma East Ind, Deccan Health C, Medi-Caps, KK Shah Hospita and Panjon.

### Is Chandra Bhagat a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Chandra Bhagat's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on CBPL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.